MalDA, Accelerating Malaria Drug Discovery is a research paper published in Trends in Parasitology (2021). On theSindex it has a DataRank of 0. It has been cited 118 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AI152533
National Institutes of Health
Grant: R01 AI152551
Bill and Melinda Gates Foundation
Grant: OPP1054480
Wellcome Trust
Grant: 203134/Z/16/Z
Medicines for Malaria Venture
Grant: R01 AI50234
Medicines for Malaria Venture
Grant: R01 AI124678
NIAID NIH HHS
Grant: R21 AI152511
Wellcome Trust
Grant: 105021/Z/14/Z
NIAID NIH HHS
Grant: R01 AI143723
NIAID NIH HHS
Grant: R21 AI152551
NIAID NIH HHS
Grant: R37 AI050234
NIAID NIH HHS
Grant: R01 AI050234
Wellcome Trust
FWCI
17.48
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Genomic analysis of single nucleotide polymorphisms in malaria parasite drug targets
Additional file 1 of Genomic analysis of single nucleotide polymorphisms in malaria parasite drug targets
Additional file 2 of Genomic analysis of single nucleotide polymorphisms in malaria parasite drug targets
Additional file 2 of Genomic analysis of single nucleotide polymorphisms in malaria parasite drug targets
Additional file 3 of Genomic analysis of single nucleotide polymorphisms in malaria parasite drug targets
Additional file 3 of Genomic analysis of single nucleotide polymorphisms in malaria parasite drug targets
Additional file 1 of Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparum
Additional file 1 of Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparum